Cargando…

Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Introduction: Unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients. Materials and Methods: We performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Asim, Mishra, Rohit, Desai, Sanket, Chandrani, Pratik, Kore, Hitesh, Sunder, Roma, Hait, Supriya, Iyer, Prajish, Trivedi, Vaishakhi, Choughule, Anuradha, Noronha, Vanita, Joshi, Amit, Patil, Vijay, Menon, Nandini, Kumar, Rajiv, Prabhash, Kumar, Dutt, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984830/ https://www.ncbi.nlm.nih.gov/pubmed/33796225 http://dx.doi.org/10.18632/oncotarget.27905

Ejemplares similares

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
por: Joshi, Asim, et al.
Publicado: (2022)

Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2017)

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes
por: Joshi, Amit, et al.
Publicado: (2019)

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
por: Noronha, Vanita, et al.
Publicado: (2017)

Association of Cutibacterium acnes with human thyroid cancer
por: Trivedi, Vaishakhi, et al.
Publicado: (2023)

Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study
por: Joshi, Amit, et al.
Publicado: (2018)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity
por: Chougule, Anuradha, et al.
Publicado: (2013)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
por: Veldore, Vidya H, et al.
Publicado: (2018)

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs
por: Butle, Ashwin, et al.
Publicado: (2021)

Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre
por: Bondili, Suresh Kumar, et al.
Publicado: (2022)

ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
por: Iyer, Prajish, et al.
Publicado: (2018)

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
por: Kate, Shruti, et al.
Publicado: (2019)

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
por: Behel, Vichitra, et al.
Publicado: (2022)

Sequential treatment with alectinib in crizotinib-resistant non-small-cell lung cancer
por: Majumdar, Swaratika, et al.
Publicado: (2018)

TMC-SNPdb 2.0: an ethnic-specific database of Indian germline variants
por: Desai, Sanket, et al.
Publicado: (2022)

Confusion worse confounded
por: Noronha, Vanita, et al.
Publicado: (2013)

Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer
por: Yadav, Neelima, et al.
Publicado: (2022)

Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 Inhibitors
por: Kapoor, Akhil, et al.
Publicado: (2022)

Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer
por: Desai, Sanket, et al.
Publicado: (2022)

Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
por: Joshi, Poonam, et al.
Publicado: (2015)

Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings
por: Kapoor, Akhil, et al.
Publicado: (2022)

Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer
por: Panda, Goutam Santosh, et al.
Publicado: (2022)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
por: Patil, Vijay Maruti, et al.
Publicado: (2017)

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience
por: Noronha, Vanita, et al.
Publicado: (2020)

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
por: Joshi, Amit, et al.
Publicado: (2017)

TMC-SNPdb: an Indian germline variant database derived from whole exome sequences
por: Upadhyay, Pawan, et al.
Publicado: (2016)

Thyroid cancer in Gardner’s syndrome: Case report and review of literature
por: Punatar, Sachin B, et al.
Publicado: (2012)

Geriatric oncology: The need of the hour
por: Joshi, Amit, et al.
Publicado: (2013)

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
por: Kapoor, Akhil, et al.
Publicado: (2020)

Systemic therapy for limited stage small cell lung carcinoma
por: Noronha, Vanita, et al.
Publicado: (2020)

Immune checkpoint inhibitors in patients with solid tumors and poor performance status: A prospective data from the real-world settings
por: Kapoor, Akhil, et al.
Publicado: (2021)

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
por: Noronha, Vanita, et al.
Publicado: (2013)

Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience
por: Chougule, Anuradha, et al.
Publicado: (2023)

Non-typhoidal Salmonella DNA traces in gallbladder cancer
por: Iyer, Prajish, et al.
Publicado: (2016)

A systematic approach to diagnosis of cystic brain lesions
por: Sharma, Vibhor, et al.
Publicado: (2013)

Crizotinib: A comprehensive review
por: Sahu, Arvind, et al.
Publicado: (2013)

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
por: Talreja, Vikas T., et al.
Publicado: (2020)

Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
por: Kumar, D. Santhosh, et al.
Publicado: (2014)

Translation and Validation of COST - FACIT (Version 2) Questionnaire into Hindi and Marathi to Assess Financial Toxicity in Indian Cancer Patients
por: Joshi, Amit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dp20rvr7ftor80daq01mmlmnmg